UniQuest, UQ's main commercialisation company that has created over 70 companies since 1984, licensed the serum production technology to Q-Sera.
Q-Sera, a biotechnology company formed out of intellectual property from Australia’s University of Queensland (UQ), has raised A$900,000 from the country’s Medical Research Commercialisation Fund (MRCF) and the Uniseed Commercialisation Fund to develop an improved blood collection tube.
UniQuest, UQ’s main commercialisation company that has created over 70 companies since 1984, licensed the serum production technology to Q-Sera.
David Henderson, managing director of UniQuest, said: "This investment is UQ’s first transaction with the MRCF, and 18th with Uniseed – that’s…
